KemPharm News

KMPHDelisted Stock  USD 5.81  0.02  0.34%   
Under 62% of KemPharm's investor base is looking to short. The analysis of current outlook of investing in KemPharm suggests that many traders are alarmed regarding KemPharm's prospects. KemPharm's investor sentiment overview provides quick insight into current market opportunities from investing in KemPharm. The current market sentiment, together with KemPharm's historical and current headlines, can help investors time the market. In addition, many technical investors use KemPharm stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
KemPharm stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of KemPharm daily returns and investor perception about the current price of KemPharm as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at benzinga.com         
Zevra Therapeutics Begins Trading as ZVRA
benzinga news
over a year ago at benzinga.com         
Zevra Therapeutics, a Rare Disease Therapeutics Company, Files Preliminary Proxy
benzinga news
over a year ago at benzinga.com         
Zevra Therapeutics to Report Fourth Quarter and Full-Year 2022 Results
benzinga news
over a year ago at globenewswire.com         
Zevra Therapeutics Announces Arimoclomol Research Featured in Two Poster Presentations at the 19th A...
Macroaxis News: globenewswire.com
over a year ago at benzinga.com         
Zevra Therapeutics Announces Arimoclomol Research Featured in Two Poster Presentations at the 19th A...
benzinga news
over a year ago at benzinga.com         
Zevra Therapeutics Announces Two Abstracts Accepted for Presentation at the 19th Annual WORLDSymposi...
benzinga news
over a year ago at globenewswire.com         
CORRECTION KemPharm Announces Corporate Name Change to Zevra Therapeutics
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
Top 5 4th Quarter Trades of HealthInvest Partners AB - GuruFocus.com
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Breakeven On The Horizon For KemPharm, Inc.
Yahoo News
over a year ago at finance.yahoo.com         
Breakeven On The Horizon For KemPharm, Inc.
Yahoo News
over a year ago at bizjournals.com         
Meet KemPharms new CEO, a West Point grad who will lead the expansion into rare disease drugs
bizjournals News
over a year ago at bizjournals.com         
Meet KemPharms new CEO, a West Point grad who will lead the expansion into rare disease drugs
bizjournals News
over a year ago at Macroaxis         
Will Berkeley Lights (NASDAQ:BLI) and Kempharm (NASDAQ:KMPH) deliver in May?
Macroaxis News
Far too much social signal, news, headlines, and media speculation about KemPharm that are available to investors today. That information is available publicly through KemPharm media outlets and privately through word of mouth or via KemPharm internal channels. However, regardless of the origin, that massive amount of KemPharm data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of KemPharm news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of KemPharm relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to KemPharm's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive KemPharm alpha.

KemPharm Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Meet KemPharms new CEO, a West Point grad who will lead the expansion into rare disease drugs
02/02/2023
2
Breakeven On The Horizon For KemPharm, Inc.
02/09/2023
3
CORRECTION KemPharm Announces Corporate Name Change to Zevra Therapeutics
02/22/2023
4
Zevra Therapeutics Announces Arimoclomol Research Featured in Two Poster Presentations at the 19th Annual WORLDSymposium 2023
02/24/2023
5
Zevra Therapeutics to Report Fourth Quarter and Full-Year 2022 Results
02/27/2023
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in KemPharm Stock

If you are still planning to invest in KemPharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KemPharm's history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance